Ping An reported 3Q26 results, with Group OPAT growing 8.3% YoY to RMB125.9bn in 9M26, slightly ahead of our estimate (+8.1% YoY, link), which implied a robust 8.2% YoY increase in 3Q26 (vs. 1Q/2Q26: +7.6%/+9.0%). Group NPAT fell 27.3% YoY to RMB96.6bn (vs. CMBI est: -29% YoY), translating into a 95% drawdown in 3Q26 (vs. 1Q/2Q26: -7.4%/+64.7%) weighed by the sharp A-share equity market pullback in 3Q. The NPAT/OPAT variation comprised 1) RMB34bn short-term investment variances from L&H segment, and 2) RMB4.5bn one-off revaluation gains on conversion values of USD/HKD-denominated convertible bonds under the backdrop of a declining share price (9M25: a loss of RMB9.3bn). P&C OPAT was the main drag to the Group (-69% YoY), due to a significant retreat in investment income partially offset by improved UW profits (+52% YoY, CMBI est). OPAT growth of L&H/PAB remained solid at 4.7%/2.2% YoY whilst that of the AM segment hiked 6.3x YoY in 9M26, thanks to enhanced AUM amid sustained active trading. NBV edged down 13.3% YoY to RMB31.0bn in 9M26, broadly in line with our forecast, reflecting a 54% YoY decline in 3Q26. The drawdown was a result of a declining FYP (-9.1% YoY) amid a margin contraction (-1.2pct YoY). P&C COR improved 1.4pct YoY to 95.6%, ahead of our estimate, implying a 3Q COR of 96.5%. Despite the weak NBV in 3Q, mgmt. guided a double-digit increase over the next three to five years with bancassurance likely to return to solid growth in 1H27E. Maintain BUY with price target of HK$81/RMB73, implying 0.8x FY26E P/EV.
L&H OPAT in solid growth, with CSM returning to growth on track. In 9M26, L&H OPAT grew 4.7% YoY to RMB82.5bn, translating into a 12.4% YoY increase in 3Q26 (1Q/2Q26: +4.6%/-3.1%). Although the insurer did not disclose CSM release/balance in quarterly results, the mgmt. mentioned in call that CSM is heading towards a positive growth trajectory with support of 1) solid new business growth, and 2) continued improving operational efficiency to offset the interest rate volatilities. We maintain our forecast on L&H CSM growth inflection within FY26E.
NBV dragged by a high base of FYP and margin decline. NBV fell 13.3% YoY to RMB31.0bn in 9M26, implying a 54.1% YoY decrease in 3Q26 (vs. 1Q/2Q26: +20.8%/-1.8%). FYP was down 9.1% YoY to RMB128.9bn mainly weighed by a high-base effect. NBV margin slid 1.2pct YoY to 24% in 9M26, as the comparative was set prior to the actuarial assumption changes as of end-FY25. By 9M26, the NBV mix of agency/bancassurance & other channels amounted to 63.1%/36.9%.
P&C combined ratio outpacing estimate but offset by investment headwinds. P&C premium income rose 3.5% YoY to RMB265bn, with auto/non-auto premiums flat/+10% YoY to RMB166bn/RMB263bn (63%/37% mix) in 9M26. P&C combined ratio improved 1.4pct YoY to 95.6% in 9M26, indicating a 3Q26 COR of 96.5% (vs. 3Q25: 100.4%, CMBI est), which boosted UW profits by 52% YoY to RMB11.6bn. Despite a strong UW performance, P&C OPAT/NPAT fell 69%/63% YoY in 9M26/ 3Q26, as a main drag to the Group profitability, mainly weighed by 3Q investment headwinds and a one-off write-off on the segment’s legacy investments per mgmt.
NIY/CIY fell on a lower rate and lagging equity performance. Total investment assets grew 5.2% from year-start to RMB6.83tn by 9M26, with non-standard debts declining to RMB286bn (4.2% mix, -0.8pct from year-start) and real-estate relevant assets staying overall manageable (3.0% mix, -0.1pct from year-start). NIY/CIY (unannualized) was down 0.3pct/3.1pct YoY in 9M26 dragged by a high base amid significant 3Q A-share equity market drawdowns and lower long-term bond yields.
Valuation: The stock is trading at 0.47x FY26E P/EV and 0.71x FY26E P/B, 1STD below its 2-year historical mean with a yield close to 7%. The stock valuation fell back evidently post 1H results, as the market baked in the high-base effect in 3Q26 and weakened investment income caused by equity market headwinds and lower bond yields. We expect to see a sector re-rating following the release of 3Q26 earnings, and remain constructive on Ping An’s 1) solid L&H OPAT growth; 2) continued de-risking of the AM segment, and 3) PAB profit enhancement. Maintain BUY, with our SOTP-derived H/A-share price target at HK$81/RMB73 (unchanged), which correspond to 0.8x FY26E P/EV and 1.2x FY26E P/B.
Key highlights of 3Q26 earnings call:
1) Updates on the 2027 jumpstart sales: The 2027 jumpstart sales would face a high NBV base (1Q26 NBV: +20.8% YoY), but the company would strengthen on top of the 2026 strategy, by focusing on the products of protection-typed and with longer-payment periods. Mgmt. expects participating products to remain as a major category in the 2027 jumpstart sales, including participating increasing sum-assured whole life insurance and participating annuity, etc.
2) Progress on new asset-liability management regulation: The company fulfils new regulatory requirements on asset-liability matching, and remains disciplined on interest rate risk exposure. Based on internal estimation, even under extreme scenarios, the company would maintain top-level coverage ratios among listed insurance peers.
3) Outlook on interest yields: Expect a prolonged low-interest rate environment, with long-term yields to remain range-bound at low levels but with limited scope for a sharp decline.
4) Asset allocation: The company will maintain a high-yield stock strategy to balance between enhancing investment returns and reducing capital market volatilities, and keeps secondary equity exposure within a reasonable range (1H26: 14.6% mix). The mgmt. does not expect a substantial increase in equity exposure in the short term.
Key risks: 1) regulatory tightening on life insurance and financial conglomerates; 2) heightened equity market volatility; 3) a prolonged low-interest rate environment; 4) intensified pricing competition in P&C industry; 5) asset quality deterioration; and 6) a significant decline in the Group capital level which could weigh on DPS growth, etc.
Company description: Founded in 1988, Ping An is a leading financial conglomerate with businesses spanning life and P&C insurance, pension, banking, brokerage, trust, and other financial services. The company pursues a technology-empowered growth strategy across core financial businesses of insurance, banking, brokerage, and asset management. As of FY25, Ping An ranked as the second-largest Life and P&C insurer in China by total written premiums. The banking business segment is operated by its subsidiary Ping An Bank (000001 CH, 58% Group stake), which has a focus on retail and SME businesses. Ping An Healthcare and Technology (1833 HK, 53% Group stake) was listed in May 2018 as China’s first listed internet-health company.



